11 min listen
Unavailable
Currently unavailable
Healthcare: How Much Do Share Prices Matter In Big-Cap Biotech?
FromIndustry Focus
Currently unavailable
Healthcare: How Much Do Share Prices Matter In Big-Cap Biotech?
FromIndustry Focus
ratings:
Length:
18 minutes
Released:
Jul 6, 2016
Format:
Podcast episode
Description
We compare Biogen's and Celgene's current valuations and consider what might be in store for Gilead Sciences now that its new hepatitis C drug is approved.
Released:
Jul 6, 2016
Format:
Podcast episode
Titles in the series (100)
Energy: What Wall Street Got Wrong This Week by Industry Focus